CAS: 32981-85-4; Bz-Rs-Iser(3-Ph)-Ome

该化合物是化学化合物,其特点是其特定的立体化学和功能组;其特点是一个苯并基组,即附属于一个苯环的碳基组;表明其具有典型芳香化合物相互作用的潜力;其存在的同位素细胞表明,其具有氨基和氢氧基功能组,有助于其在极溶剂中的潜在溶解性;甲基酯功能显示,异硫酸的碳本体酸组已经进入蒸发阶段,可以增加脂性并影响其再活动;该化合物可能因其结构相似而表现出生物活动,使其与氨基酸相似,使其对制药化学感兴趣;其化学结构(2R,3S)配置所描述的立体化学对于其生物相互作用至关重要,因为原子的空间组合可显著影响化合物在生物系统中的特性和行为.总体而言,该化合物独特的结构位置是药用化学和相关领域的可能有价值的分子.

结构式图片

上下游产品

CAS号98-88-4 苯甲酰氯 | CAS号145041-37-8 methyl (2R,3S)-... | CAS号186581-53-3 重氮甲烷 | CAS号132201-33-3 N-苯甲酰基-(2R,3S)-... | CAS号67-56-1 甲醇 | CAS号100-44-7 氯化苄 | CAS号33069-62-4 紫杉醇 | CAS号32981-85-4 (2R,3S)-3-苯甲酰氨基... | CAS号132201-33-3 N-苯甲酰基-(2R,3S)-... | CAS号136561-53-0 (2R,3S)-3-苯基异丝胺酸 | CAS号153652-70-1 (4S,5R)-3-苯甲酰基-...

合成工艺路线路线简述

    Methyl Cinnamate置于lipase Ps-C M. Miehei,Sodium Hydride,Caesium Carbonate,Magnesium Bromide Ethyl Etherate体系中,用 四氢呋喃,乙醚,正己烷,二氯甲烷,Mineral Oil 作为反应溶剂,化学反应 116.0H,反应生成 N-苯甲酰基-(2R,3S)-3-苯基异丝氨酸甲酯
    参考文献:Regio-And Stereoselective Methods For The Conversion Of (2S,3R)-β-Phenylglycidic Acid Esters To Taxoids And Other Enantiopure (2R,3S)-Phenylisoserine Esters
    标题:Regio-And Stereoselective Methods For The Conversion Of (2S,3R)-β-Phenylglycidic Acid Esters To Taxoids And Other Enantiopure (2R,3S)-Phenylisoserine Esters
    摘要:提出了一种新的高效方法,用于合成含类固醇的对映体前体,即 (2R,3S)-和 (2S,3R)-N-苯甲酰基苯基异丝氨酸的甲酯以及类似的类固醇酯.该方法基于对相应的反式-β-苯基甘氨酸对映体进行区域和立体选择性氢溴酸分解,对得到的 3-溴烷烃进行 O-酰基氨基甲酰化的连续反应,分子内环化为 4-苯基恶唑啉-2-酮-5-羧酸衍生物,以及恶唑啉酮开环.
    DOI:10.1007/s11172-012-0302-4

    海关参考信息

    专利信息


    专利号:US-6020174-A
    优先权日:1992-07-27
    标题:Chemoenzymatic synthesis of the taxol C-13 side chain N-benzolyl- (2R,3S)-Phenylisoserine
    发明人:CHEN CHING-SHIH; GOU DA-MING; LIU YEUK-CHUEN
    权利人:RHODE ISLAND EDUCATION
    摘要:(2R,3S)- and (2S,3R)-enantiomers of trans- beta -phenylglycidic esters, prepared by lipase-mediated enantioselective transesterification, are used for the synthesis of the taxol C-13 side chain with good yield.

    专利号:US-6509506-B1
    优先权日:1997-05-21
    标 题 :Two step synthesis of D- and L- α-amino acids and D- and L- α-amino aldehydes
    发明人:SHARPLESS K BARRY; LI GUIGEN
    权利人:SCRIPPS RESEARCH INST
    摘要:D- and L- α-amino acids and D- and L-α-amino aldehydes are synthesized from olefin substrates in two steps. The first step is a catalyzed asymmetric aminohydroxylation addition reaction to the olefin substrate. The addition reaction is catalyzed by osmium and is co-catalyzed by chiral ligands. The chiral ligands, in addition to being co-catalysts with the osmium, also serve to direct the addition reaction regioselectively and enantioselectively, divalent ligands are preferred over monovalent ligands because of their enhanced regio-and enantio-selectivity. As an oxidant nitrogen source for the addition reaction, either a carbamate or sulfonamide may be employed. If carbamate is employed as an oxidant nitrogen source, the resultant β-hydoxycarbamate is deprotected to yield the corresponding β-hydroxyamine. If sulfonamide is employed as an oxidant nitrogen source, the resultant β-hydroxysulfonamide is deprotected to yield the corresponding β-hydroxyamine. The resultant β-hydroxyamine is then selectively oxidized in a second synthetic step to produce the desired D- and L- α-amino acid or D- and L-α-amino aldehyde.

    专利号:US-5994583-A
    优先权日:1996-05-22
    标 题 :Two step synthesis of D- and L- α-amino acids and D- and L- α-amino-aldehydes
    发明人:SHARPLESS K BARRY; LI GUIGEN
    权利人:SCRIPPS RESEARCH INST
    摘要:D- and L-α-amino acids and D- and L-α-amino aldehydes are synthesized from olefin substrates in two steps. The first step is a catalyzed asymmetric aminohydroxylation addition reaction to the olefin substrate. The addition reaction is catalyzed by osmium and is co-catalyzed by chiral ligands. The chiral ligands, in addition to being co-catalysts with the osmium, also serve to direct the addition reaction regioselectively and enantioselectively. Divalent ligands are preferred over monovalent ligands because of their enhance regio- and enantio-selectivity. As an oxidant nitrogen source for the addition reaction, either a carbamate or sulfonamide may be employed. If carbamate is employed as an oxidant nitrogen source, the resultant β-hydroxycarbamate is deprotected to yield the corresponding β-hydroxyamine. If sulfonamide is employed as an oxidant nitrogen source, the resultant β-hydroxysulfonamide is deprotected to yield the corresponding β-hydroxyamine. The resultant β-hydroxyamine is then selectively oxidized in a second synthetic step to produce the desired D- and L-α-amino acid or D- and L-α-amino aldehyde.

    专利号:WO-9310076-A1
    优先权日:1991-11-22
    标 题 :Synthesis and optical resolution of the taxol side chain and related compounds
    发明人:PETERSON JOHN R; ZJAWIONY JORDAN K; ROGERS ROBIN D
    权利人:UNIV MISSISSIPPI
    摘要:This invention relates to a method for the production of a substantially optically pure taxane side chain comprising the steps of synthesizing a racemic mixture of enantiomers of the taxane side chain that is capable of exhibiting conglomerate behavior and resolving the substantially optically pure enantiomers by direct crystallization methods. This invention also relates to the semisynthesis of taxanes such as taxol through coupling the substantially optically pure taxane side chain to a taxane ring nucleus.

    专利号:US-5932758-A
    优先权日:1995-07-04
    标 题 :Process for the production β-amino-α-hydroxycarboxylic acids and derivatives thereof
    发明人:STINGL KLAUS; KOTTENHAHN MATTHIAS; DRAUZ KARLHEINZ
    权利人:DEGUSSA
    摘要:Disclosed is a process for producing β-amino-α-hydroxycarboxylic acid derivatives of general formula (2R,3S)- or (2S,3E)-N-(X,Y)-3-amino-2-hydroxy-3-phenyl propionic acid-Z of Formula I, ##STR1## e.g. of (2E,3S)-3-amino-2-hydroxy-3-phenyl propionic acid or (2R,3S)-N-benzoyl-3-amino-2-hydroxy-3-phenyl propionic acid methylester. Compounds of type I are valuable intermediates in the total synthesis of Taxols which can be used in the treatment of various forms of cancer.

    专利号:WO-9744312-A1
    优先权日:1996-05-22
    标题:TWO STEP SYNTHESIS OF D- AND L- α-AMINO ACIDS AND D- AND L- α-AMINO ALDEHYDES
    上海金和生物制药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.biotaxu.com
    电话: 021-51915565👤
    📞上海金和生物制药有限公司 ⚠️参考联系方式

    销售电话:021-51915565
    邮箱:zhangbin@biotaxu.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海贝美医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.biomanpharma.com
    企业联系电话:021-33738120👤
    📞上海贝美医药科技有限公司 ⚠️参考联系方式
    联系人:郑经理
    电话:021-33738120
    手机:15000110506
    传真:021-23025272
    邮箱:info@bioman.com.cn
    通信地址: 上海市闵行区园文路28号金源中心2015室
    邮编: 201611
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市闵行区园文路28号金源中心2015室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知